¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myocardial insufficiency"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ, »çÀ̸·½É±Ù°æ»öÁõ
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ
  • aortic insufficiency
    ´ëµ¿¸ÆÆÇ¸·±â´ÉºÎÀü
  • accommodative insufficiency
    Á¶ÀýºÎÀü
  • autonomic insufficiency
    ÀÚÀ²½Å°æºÎÀü
  • adrenocortical insufficiency
    ºÎ½Å°ÑÁúºÎÀü, ºÎ½ÅÇÇÁúºÎÀü
  • convergence insufficiency
    ´«¸ðÀ½ºÎÀü, ÆøÁÖºÎÀü
  • convergence insufficiency exotropia
    ´«¸ðÀ½ºÎÁ·¿Ü»ç½Ã, ÆøÁÖºÎÁ·¿Ü»ç½Ã
  • coronary insufficiency
    °ü»óµ¿¸ÆºÎÀü, ½ÉÀ嵿¸ÆÇ÷·ùÀúÇÏ
  • divergence insufficiency
    ´«¹ú¸²ºÎÁ·, °³»êºÎÁ·
  • evacuatory insufficiency
    ¹èÃâºÎÀü
  • erectile insufficiency
    ¹ß±âºÎÀü
  • gonadal insufficiency
    »ý½Ä»ù±â´ÉºÎÀü
  • insufficiency
    1. ºÎÀü 2. ºÎÁ·(Áõ) 3. ±â´ÉºÎÀü
  • mitral insufficiency
    ½Â¸ðÆÇ(±â´É)ºÎÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory insufficiency
    È£Èí±â´ÉºÎÁ·
  • valvular insufficiency
    ½ÉÀåÆÇ¸·ºÎÁ·Áõ
  • ventilatory insufficiency
    ȯ±âºÎÁ·
  • myocardial anoxia
    ½ÉÀå±ÙÀ°¹«»ê¼ÒÁõ
  • myocardial bridging
    ½É±Ù´Ù¸®
  • myocardial contractility
    ½ÉÀå±ÙÀ°¼öÃà·Â, ½ÉÀå±ÙÀ°¼öÃ༺
  • myocardial contraction
    ½ÉÀå±ÙÀ°¼öÃà
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • myocardial depressant factor
    ½ÉÀå±Ù¾ïÁ¦ÀÎÀÚ
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical insufficiency
    ºÎ½ÅÇÇÁúºÎÀüÁõ(Üùãìù«òõÝÕîïñø).
  • adrenocortical insufficiency
    ºÎ½ÅÇÇÁú ºÎÀüÁõ(¡­ù«òõÜôîîñø)
  • aortic insufficiency
    ´ëµ¿¸ÆÆÇÆó¼âºÎÀü(Áõ).
  • arterial insufficiency
    µ¿¸ÆºÎÀüÁõ.
  • genital insufficiency
    ¼º±â´ÉºÎÀü(àõѦÒöÝÕîï).
  • gonadal insufficiency
    ¼º¼±ºÎÀü(¡­ÝÕîï).
  • hepatic insufficiency
    °£(±â´É)ºÎÀü.
  • insufficiency of adrenal cortex
    ºÎ½ÅÇÇÁúºÎÀü
  • insufficiency of convergence
    ´«¸ðÀ½ºÎÁ·, ÆøÁÖºÎÁ·
  • insufficiency of divergence
    ´«¹ú¸²ºÎÁ·, °³»êºÎÁ·
  • insufficiency of stimulation
    ÀڱغÎÀü(ô§Ð½ ÝÕîï).
  • insufficiency ³ª insufficientia
    ºÎÀü(Áõ)(ÝÕîïñø), (±â´É)ºÎÀü(ѦÒöÝÕ îï).
  • pituitary adrenocortical insufficiency
    Çϼöü¼º ºÎ½ÅÇÇÁú(±â´É)ÀúÇÏ(Áõ)(¡­ àõÜùãìù«òõѦÒöî¸ù»ñø).
  • pituitary adrenocortical insufficiency
    Çϼöü¼º ºÎ½ÅÇÇÁú(±â´É)ÀúÇÏ(Áõ)(ù»á÷ô÷àõ Üùãìù«òõ(ѦÒö)î¸ù»(ñø))
  • pituitary insufficiency
    ³úÇϼöü±â´ÉºÎÀü(¡­Ñ¦ÒöÝÕîï).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myocardial degeneration
    ½É±Ùº¯¼º(¡­Ü¨àõ).
  • myocardial degeneration
    ½É±Ùº¯¼º(ãýÐÉܨàõ)
  • myocardial depressant
    ½É(±Ù)¾ïÁ¦¾à(¡­åäð¤å·), ½É±Ù¾ïÁ¦Á¦.
  • myocardial depressant
    ½É±Ù¾ïÁ¦Á¦, ½É(±Ù)¾ïÁ¦¾à(¡­åäð¤å·).
  • myocardial depressant factor
    ½É±Ù¾ïÁ¦ÀÎÀÚ.
  • myocardial depression
    ½É±Ù¾ïÁ¦
  • myocardial disease
    ½É±ÙÁúȯ(¡­òðü´).
  • myocardial disease
    ½É±ÙÁúȯ(¡­òðü´)
  • myocardial failure
    ½É±ÙºÎÀü(¡­ÝÕîï).
  • myocardial fibrosis
    ½É±Ù¼¶À¯Áõ(¡­àéë«ñø).
  • myocardial function
    ½É±Ù±â´É.
  • myocardial hypoxia
    ½É±ÙÀú»ê¼ÒÁõ(ãýÐÉî¸ß«áÈñø).
  • myocardial infarction
    ½É±Ù°æ»öÁõ(¡­ÌÛßáñø).
  • myocardial infarction
    ½É±Ù°æ»öÁõ(¡­ÌÛßáñø)
  • myocardial infarction
    ½É±Ù°æ»ö
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • valvular insufficiency
    ½ÉÆÇ¸·ºÎÀüÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CRI Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AMI acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial...
IMI immunologically measurable insulin; impending myocardial infarction; Imperial Mycological Institute ...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CIBIS Cardiac Insufficiency BIsoprolol Study
CVI Chronic Venous Insufficiency
CRI Chronic renal insufficiency
CRI Chronic respiratory insufficiency
MI Mitral insufficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adrenal insufficiency
    ºÎ½Å ºÎÀü, ºÎ½Å ±â´ÉºÎÀü, ºÎ½Å±â´É ºÎÀüÁõ
    1. ºÎ½Å±â´ÉÀÇ ºñÁ¤»óÀû ÀúÇÏ. ¿¹ÄÁ´ë ¿¡µð½¼º´¿¡¼­ º¼ ¼ö ÀÖ´Ù. 2. ±Þ¼º ¶Ç´Â ¸¸¼º ÁõÈıºÀ¸·Î¼­ ³ªÅ¸³ª¸ç ÁÖµÈ Æ¯Â¡Àº ÀúÇ÷¾ÐÀ̸ç, ÀϹÝÀûÀÎ Áõ»óÀº ¼è¾à, üÁß°¨¼Ò, ¿À½É, ±¸Åä µîÀÌ´Ù. ½ºÅ×·ÎÀ̵å Á¦À縦 Àå±â°£ Åõ¿© ¹Þ¾Æ¿Â ȯÀÚµéÀº Ä¡°ú ½Ã¼úÀ̳ª Á¤½ÅÀû ½ºÆ®·¹½º¿¡ ÀÇÇØ ÀÀ±Þ »çŰ¡ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. ÃÖ¼±ÀÇ Ä¡·á´Â ¿¹¹æÀε¥ Ä¡·á ¾à¼Ó Àü¿¡ ´ã´çÀÇ»ç¿Í »óÀÇÇÏ¿© ½ºÅ×·ÎÀ̵å Á¦À縦 ºÎ°¡ÀûÀ¸·Î Åõ¿©ÇÑ ÈÄ ½Ã¼úÇÏ¿©¾ß ÇÑ´Ù.
  • arterial insufficiency
    µ¿¸Æ ºÎÀüÁõ
  • chronic insufficiency of adrenal cortex
    ºÎ½Å ÇÇÁúÀÇ ¸¸¼º ºÎÀü
    ÇǺΰ¡ °¥»öÀ» ¶ì°Ô µÈ´Ù. Á¡¸·¿¡ »ö¼Ò°¡ Ä§ÂøÇÑ´Ù. ¾àÇÑ ½ÉÀåÀÇ È°µ¿, ¹«±â·ÂÁõ, ¼³»ç, ±¸Åä, ºóÇ÷.
  • cortical insufficiency
    ÇÇÁú ±â´É ºÎÀüÁõ
  • insufficiency
    ±â´É ºÎÀüÁõ, Æó¼â ºÎÀü, ºÎÀüÁõ, ±â´É ºÎÀü
    Á¤ÇØÁø Ã¥ÀÓÀ» ¿Ï¼öÇϱ⿡ ºÒ¿ÏÀüÇϰųª ºÎÀû´çÇÑ »óÅÂ.
  • mitral insufficiency
    ½Â¸ðÆÇ Æó¼â ºÎÀü, ½Â¸ðÆÇ Æó¼â ºÎÀüÁõ
    µ¿ÀǾî=mitral regurgitation.
  • palatopharyngeal insufficiency
    ±¸°³ ÀεΠ±¸Á¶ ÀÌ»ó
  • pancreatic insufficiency
    ÃéÀå ±â´É ºÎÀü
    ÃéÀåÀÇ Æ¯È÷ ¿ÜºÐºñ¼º ±â´ÉÀÌ ºÒÃæºÐÇϱ⠶§¹®¿¡ Èí¼ö ºÒ·®¼º ÁõÈıºÀ» ³ªÅ¸³»´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. ü¿Ü ºÐºñ¼±ÀÇ ¿¹ºñ ´É·ÂÀº ±ØÈ÷ Å©°í ÀÌ¿Í °°Àº º´Å¿¡¼­´Â ±¤¹üÀ§ÇÏ°Ô Ãë ½ÇÁúÀÇ È²Æó°¡ Á¸ÀçÇÑ´Ù.
  • pituitary insufficiency
    ³úÇϼöü ±â´É ºÎÀü
  • pulmonary insufficiency
    Æó µ¿¸ÆÆÇ¸· Æó¼â ºÎÀü, Æó µ¿¸ÆÆÇ¸· Æó¼â ºÎÀüÁõ, Æó ±â´É ºÎÀü
  • valvular insufficiency
    ½ÉÆÇ¸· ºÎÀüÁõ
  • ventilatory insufficiency
    ȯ±â ºÎÀü
  • vertebral insufficiency
    ôÃß ºÎÀü
  • vertebrobasilar insufficiency
    ôÃß±âÀü Ç÷°üºÎÀü
    ³ë³â¿¡¼­ ÈçÇÑ ÇöÈÆÀÇ ¿øÀÎÀÌ´Ù. ÈçÈ÷ ÀÚ¼¼ º¯È­ ¶Ç´Â ¸ñ ½ÅÀü¿¡ ÀÇÇØ À¯¹ßµÈ´Ù. ôÃß±âÀú°èÀÇ Ç÷·ù °¨¼Ò´Â ºñħ½ÀÀûÀ¸·Î MRÇ÷°ü Á¶¿µ¼úÀ» ÅëÇØ ¾Ë ¼ö ÀÖ´Ù. ÀÓ»óÀû Ä¡·á·Î´Â Ç÷°ü È®ÀåÁ¦, ¾Æ½ºÇǸ°, ±×¸®°í ¿îµ¿¿ä¹ýÀÌ ÀÖ´Ù. ÆíµÎÅëÀÌ ÇöÈÆ ¹ßÀÛÀ» À¯¹ßÇÒ ¼ö ÀÖ´Ù. ÀüÇüÀû µÎÅëÀÇ ÇüŸ¦ ÃëÇÒ °æ¿ì Áø´ÜÀº ºÐ¸íÇÏ´Ù. ±×·¯³ª Ç×»ó ±×·¸Áö´Â ¾Ê´Ù. ¾çÂÊ ÆíµÎÅë°ú Àç¹ß¼º ÇöÈÆÀÇ º´·ÂÀÌ Àִ ȯÀÚ¿¡¼­´Â adrenergic blocking agents¿Í ergotÀÌ ÇÕ´çÇÏ´Ù. ³ú°£¿¡ ³ú½Å°æ ÀÔ±¸ ±âÀúºÎ¸¦ °ø±ÞÇÏ´Â Ç÷°ü°í¸®µéÀº ÀÌ»óÀ» À¯¹ßÇÏ´Â °ÍÀ¸·Î º¸¿©Áø´Ù. ³Î¸® ÀνĵǾî Áö°í ÀÖ´Â ¿¹µéÀº ¾È¸é ÇÑÂÊÀÇ ¶³¸²°ú »ïÂ÷½Å°æÅë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
myocardial ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (coronary arteriosclerosis), to obstruction by a thrombus (coronary thrombosis), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).
(12 Dec 1998)
myocardial necrosis Irreversible destruction of myocardial (heart muscle) cells.
(27 Sep 1997)
myocardial perfusion imaging <radiology> (thallium scanning) thallium (Tl) 201, acts as potassium analog, dose 2.0 - 3.0 mCi at peak exercise, 4% of injected dose reaches myocardium, imaging: exercise (1-5 min), redistribution (3-4 hrs), views: anterior, LAO 45', left lateral, interpretation: normal, reversible abnormalitymost likely to be exercise-induced ischemia, nonreversible abnormalitymost likely to be prior myocardial infarction, reverse redistribution most likely to be normal areas wash out faster, lung activity most likely to be LV failure during exercise see also: dipyridamole test, nuclear cardiology
(12 Dec 1998)
myocardial reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing myocardial reperfusion injury.
(12 Dec 1998)
myocardial reperfusion injury Functional, metabolic, or structural changes in ischemic heart muscle thought to result from reperfusion to the ischemic areas. Changes can be fatal to muscle cells and may include oedema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include haemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion.
(12 Dec 1998)
myocardial revascularization The restoration of blood supply to the myocardium.
(12 Dec 1998)
myocardial rigor mortis Irreversible contraction of the left ventricle of the heart as a complication seen in the early period of cardiopulmonary bypass and now avoided by appropriate cardioplegic solutions.
Synonym: myocardial rigor mortis, stone heart.
(05 Mar 2000)
myocardial stunning Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue.
(12 Dec 1998)
posterior myocardial infarction Infarction involving the posterior wall of the heart; also formerly used erroneously of infarction's involving the inferior or diaphragmatic surface of the heart.
(05 Mar 2000)
silent myocardial infarction Infarction that produces none of the characteristic symptoms and signs of myocardial infarction.
(05 Mar 2000)
subendocardial myocardial infarction Infarction that involves only the layer of muscle subjacent to the endocardium.
(05 Mar 2000)
nontransmural myocardial infarction Necrosis of heart muscle that fails to extend from the endocardium to the epicardium, often erroneously considered relatively benign.
(05 Mar 2000)
diaphragmatic myocardial infarction Infarction in which the inferior or diaphragmatic wall of the heart is involved, producing indicative changes in leads II, III, and aVF in the electrocardiogram.
Synonym: diaphragmatic myocardial infarction.
(05 Mar 2000)
inferior myocardial infarction Infarction in which the inferior or diaphragmatic wall of the heart is involved, producing indicative changes in leads II, III, and aVF in the electrocardiogram.
Synonym: diaphragmatic myocardial infarction.
(05 Mar 2000)
inferolateral myocardial infarction Infarction involving the inferior and lateral surfaces of the heart and producing indicative changes in the electrocardiogram in leads II, III, aVF, V5, and V6.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á